Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Classifica tra le azioni #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Prezzo delle azioni
$25.28
Ultima sincronizzazione: 2026-09-18
Capitalizzazione di mercato
$1.01B
Variazione (1 giorno)
-2.29%
Variazione (1 anno)
-37.84%
Paese
GB
Scambia GSK plc (GSK)

Categoria

Margine operativo per GSK plc (GSK)
Margine operativo al September 2026 TTM: 24.12%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di GSK plc, il margine operativo attuale (TTM) è 24.12%. Alla fine del 2024, il margine operativo era 18.05%.
Storico del margine operativo per GSK plc da 2000 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) 24.12% 9.89%
2025 21.95% 21.61%
2024 18.05% -21.73%
2023 23.06% 1.18%
2022 22.79% 4.11%
2021 21.89% -8.79%
2020 24.00% 4.08%
2019 23.06% -11.14%
2018 25.95% -1.78%
2017 26.42% 7.88%
2016 24.49% 31.31%
2015 18.65% -12.40%
2014 21.29% -21.58%
2013 27.15% 10.55%
2012 24.56% -11.72%
2011 27.82% 58.61%
2010 17.54% -41.06%
2009 29.76% -6.09%
2008 31.69% -3.44%
2007 32.82% 1.61%
2006 32.30% 7.45%
2005 30.06% 8.83%
2004 27.62% -7.13%
2003 29.74% 13.64%
2002 26.17% -11.94%
2001 29.72% 13.61%
2000 26.16% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
43.92% -98.18%
US
26.81% -98.89%
US
29.32% -98.78%
US
26.59% -98.90%
CH
16.65% -99.31%
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.